Screener / SEC EDGAR /CIK 0001099219 /10-K filed Feb 19, 2026, compared with Feb 21, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Financials · Life Insurance

MetLife MET

Compare with peers Embed
SEC comment letters, last 20 years

1 review of MET's filings by SEC staff

UPLOAD and CORRESP
Reviews 1 latest letter Sep 22, 2022
Questions asked 3 each answered in the company's own letter
No closing letter 0 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 1 UPLOAD
  2. 2. Questions in them 3 numbered comments
  3. 3. Company replies 1 CORRESP
  4. 4. Reviews closed 1 of 1 closing letter

Half the closed reviews took 46 days or less from the first letter to the closing letter.

Schedule 14A

2022-09-22 to 2022-11-07 · 3 questions · 1 letter from the SEC, 1 from the company
Review closed 2022-11-07
Controls
Definitive Proxy Statement on Schedule 14A filed April 29, 2022 · General
SEC asked (1)
Please expand your discussion of the reasons you believe that your leadership structure is appropriate, addressing your specific characteristics or circumstances. In your discussion, please also address the circumstances under which you would consider having the Chair and CEO roles filled by a single individual, when shareholders would be notified of any such change, and whether you will seek prior input from
Rest of the question

shareholders.

MET answered
MetLife will expand in its future proxy statement disclosures the discussion of the reasons it believes the current leadership structure is the most appropriate. The disclosure will address the specific characteristics and circumstances, and how any change to the current structure would be considered.
Read in the reply
Definitive Proxy Statement on Schedule 14A filed April 29, 2022 · General
SEC asked (2)
Please expand upon the role that your Chairman plays in the leadership of the board. For example, please enhance your disclosure to address whether or not your Chairman may: • represent the board in communications with shareholders and other stakeholders; • require board consideration of, and/or override your CEO on, any risk matters; or • provide input on design of the board itself.
MET answered
MetLife’s future proxy statement disclosures concerning the role of the Chairman will address the extent to which the Chairman may represent the board in communications with shareholders, the board’s consideration of risk matters, the role of the CEO and the design of the board.
Read in the reply
Definitive Proxy Statement on Schedule 14A filed April 29, 2022 · General
SEC asked (3)
Please expand upon how your board administers its risk oversight function. For example, please disclose: • why your board elected to retain direct oversight responsibility for the design and implementation of risk management and risks associated with leadership succession planning, rather than assign oversight to a board committee; • the timeframe over which you evaluate risks (e.g., short-term, intermediate-term,
Rest of the question

or long-term) and how you apply different oversight standards based upon the immediacy of the risk assessed; • whether you consult with outside advisors and experts to anticipate future threats and trends, and how often you re-assess your risk environment; • whether you have a Chief Compliance Officer and to whom this position reports; and • how your risk oversight process aligns with your disclosure controls and procedures.

MET answered
MetLife will address in its future proxy statement disclosures decisions regarding the board’s approach to risks associated with leadership succession, the timeframe for evaluating risks, the involvement of outside advisors, the role of the Chief Compliance Officer and the alignment of risk oversight with the Company’s disclosure controls and procedures.

If we may be of assistance in answering any questions that may arise in connection with the staff’s review of our response letter, please call me at 212-578-2640.
Read in the reply

Also in this review: closing letter, 2022-11-07

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 3 letters filed since 2022-09-22. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MET/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.